V Britain has approved the Pfizer COVID-19 pill for patients over the age of 18 who have mild or moderate symptoms and are at high risk of severe disease, Reuters reported.
The approval comes at a time when the country is trying to mobilize resources amid a record number of new COVID-19 cases registered yesterday.
According to available data, the paxlovid pill is most effective when taken during the early stages of COVID-19.,
announced today the British Agency for Regulation of Medicines and Health Products, recommending that the drug be used within five days of the onset of symptoms.
Pfizer said this month that paxlovid has shown nearly 90 percent efficacy in preventing hospitalization
and fatal in high-risk patients, and according to the latest laboratory data, the drug remains effective against the rapidly spreading Coronvirus Omicron variant.
“We now have another antiviral drug to treat COVID-19 that can be taken orally instead of intravenously.
This means that it can be taken outside hospitals“,
said in a statement the head of the British drug regulator June Raine.
They shortened the time for setting a booster dose
There are them: the good news of the pandemic
COVID-19: Finland bans unvaccinated foreigners
How can you get a “green certificate” for antibodies
How many antibodies are needed to protect us from COVID-19
“We will not be vaccinated. This is our personal risk!”
COVID-19: Record of new cases in a number of European countries
